Yasuteru Kondo, MD, PhD, is Vice Director of Sendai Tokushukai Hospital and Visiting Associate Professor at Kumamoto University, Japan. He graduated from Tohoku University School of Medicine in 2000 and earned his PhD there in 2006. His experience includes research at the University of Southern California, an assistant professorship at Tohoku University Hospital, and leadership of the Hepatology Department and Liver Cancer Treatment Center at Sendai Kousei Hospital. His research focuses on liver immunology, viral hepatitis, and multimodal treatment of hepatocellular carcinoma. His notable work includes a first-author study of Ultra-FP therapy combining DEB-TACE with hepatic arterial infusion chemotherapy (Scientific Reports, 2022). He is a Fellow of the American Association for the Study of Liver Diseases and a councilor of the Japan Society of Hepatology and the Japanese Society of Gastroenterology.